Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Ellis

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Plos One|October 22, 2013
The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancerChristopher H Lieu, Hai Tran, Zhi-Qin Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Clinical and in vitro studies of imatinib in advanced carcinoid tumorsJames C Yao, Jun X Zhang, Asif Rashid, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 30, 2004
Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinomaIsabelle Bedrosian, Miguel A Rodriguez-Bigas, Barry Feig, et al.
Oncology (Williston Park, N.Y.)|January 11, 2012
Perspective on...the new PSA screening recommendationsThomas Marsland, Francis Arena, Alan Yeilding, et al.
Neurotoxicology|July 2, 2026
Zebrafish Behavioral Assessment as a First-Tier Whole-Organism NAM for Developmental Neurotoxicity: A Multi-Laboratory EvaluationLisa Truong, Jui-Hua Hsieh, Lee Ellis, et al.
Diseases of the Colon and Rectum|January 5, 2006
Outcome after curative resection for locally recurrent rectal cancerIsabelle Bedrosian, Geoffrey Giacco, Lee Pederson, et al.
International Journal of Cancer|September 1, 2019
A chirality-dependent action of vitamin C in suppressing Kirsten rat sarcoma mutant tumor growth by the oxidative combination: Rationale for cancer therapeuticsXinggang Wu, Mikyung Park, Dilara A Sarbassova, et al.
Frontiers in Pharmacology|February 11, 2022
Metabolomic Fingerprint of Behavioral Changes in Response to Full-Spectrum Cannabis ExtractsZaid H Maayah, Pamela J F Raposo, Heidi Silver, et al.
Cancer|October 4, 2013
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapyAtin Agarwal, George J Chang, Chung-Yuan Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatmentPhilip A Philip, Margaret Mooney, Deborah Jaffe, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Plos One|October 22, 2013
The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancerChristopher H Lieu, Hai Tran, Zhi-Qin Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Clinical and in vitro studies of imatinib in advanced carcinoid tumorsJames C Yao, Jun X Zhang, Asif Rashid, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 30, 2004
Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinomaIsabelle Bedrosian, Miguel A Rodriguez-Bigas, Barry Feig, et al.
Oncology (Williston Park, N.Y.)|January 11, 2012
Perspective on...the new PSA screening recommendationsThomas Marsland, Francis Arena, Alan Yeilding, et al.
Neurotoxicology|July 2, 2026
Zebrafish Behavioral Assessment as a First-Tier Whole-Organism NAM for Developmental Neurotoxicity: A Multi-Laboratory EvaluationLisa Truong, Jui-Hua Hsieh, Lee Ellis, et al.
Diseases of the Colon and Rectum|January 5, 2006
Outcome after curative resection for locally recurrent rectal cancerIsabelle Bedrosian, Geoffrey Giacco, Lee Pederson, et al.
International Journal of Cancer|September 1, 2019
A chirality-dependent action of vitamin C in suppressing Kirsten rat sarcoma mutant tumor growth by the oxidative combination: Rationale for cancer therapeuticsXinggang Wu, Mikyung Park, Dilara A Sarbassova, et al.
Frontiers in Pharmacology|February 11, 2022
Metabolomic Fingerprint of Behavioral Changes in Response to Full-Spectrum Cannabis ExtractsZaid H Maayah, Pamela J F Raposo, Heidi Silver, et al.
Cancer|October 4, 2013
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapyAtin Agarwal, George J Chang, Chung-Yuan Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatmentPhilip A Philip, Margaret Mooney, Deborah Jaffe, et al.
Pageof 5